Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Data Interpretation, Statistical | 8 | 2021 | 191 | 2.310 |
Why?
|
Epidemiologic Studies | 5 | 2023 | 33 | 2.300 |
Why?
|
Cancer Survivors | 11 | 2024 | 79 | 2.230 |
Why?
|
Menopause, Premature | 5 | 2022 | 25 | 2.120 |
Why?
|
Pregnancy | 48 | 2024 | 2215 | 2.080 |
Why?
|
Menstrual Cycle | 11 | 2025 | 81 | 1.940 |
Why?
|
Bias | 8 | 2024 | 108 | 1.860 |
Why?
|
Menopause | 14 | 2024 | 249 | 1.800 |
Why?
|
Diabetes, Gestational | 7 | 2023 | 138 | 1.780 |
Why?
|
Live Birth | 8 | 2024 | 20 | 1.770 |
Why?
|
Anti-Mullerian Hormone | 10 | 2022 | 63 | 1.620 |
Why?
|
Infertility, Female | 4 | 2024 | 44 | 1.600 |
Why?
|
Progesterone | 8 | 2017 | 158 | 1.540 |
Why?
|
Birth Weight | 8 | 2022 | 81 | 1.520 |
Why?
|
Female | 122 | 2025 | 30757 | 1.520 |
Why?
|
Fertilization in Vitro | 12 | 2022 | 83 | 1.480 |
Why?
|
Adult | 89 | 2025 | 15695 | 1.460 |
Why?
|
Biomarkers | 18 | 2024 | 1306 | 1.450 |
Why?
|
Reproductive Techniques, Assisted | 6 | 2021 | 31 | 1.410 |
Why?
|
Reproduction | 7 | 2021 | 89 | 1.400 |
Why?
|
Prospective Studies | 38 | 2022 | 3069 | 1.400 |
Why?
|
Risk Factors | 40 | 2025 | 4990 | 1.360 |
Why?
|
Humans | 139 | 2025 | 59440 | 1.320 |
Why?
|
Reproductive Health | 3 | 2021 | 24 | 1.290 |
Why?
|
Infertility | 6 | 2023 | 30 | 1.220 |
Why?
|
Exercise | 13 | 2024 | 883 | 1.210 |
Why?
|
Logistic Models | 8 | 2020 | 1235 | 1.200 |
Why?
|
Models, Statistical | 10 | 2020 | 299 | 1.170 |
Why?
|
Case-Control Studies | 12 | 2019 | 1054 | 1.160 |
Why?
|
Young Adult | 45 | 2025 | 4273 | 1.160 |
Why?
|
Neoplasms | 15 | 2024 | 1232 | 1.150 |
Why?
|
Oocyte Retrieval | 5 | 2017 | 12 | 1.130 |
Why?
|
Abortion, Spontaneous | 7 | 2022 | 29 | 1.130 |
Why?
|
Fertility Agents, Female | 4 | 2017 | 6 | 1.120 |
Why?
|
Luteinizing Hormone | 6 | 2014 | 98 | 1.090 |
Why?
|
Premenstrual Syndrome | 9 | 2019 | 96 | 1.090 |
Why?
|
Ovarian Reserve | 3 | 2022 | 8 | 1.090 |
Why?
|
Ovulation Induction | 3 | 2017 | 12 | 1.040 |
Why?
|
Spermatozoa | 9 | 2022 | 253 | 0.980 |
Why?
|
Fertility | 8 | 2024 | 78 | 0.960 |
Why?
|
Follicle Stimulating Hormone | 8 | 2021 | 82 | 0.940 |
Why?
|
Cohort Studies | 22 | 2023 | 2376 | 0.930 |
Why?
|
Aspirin | 6 | 2020 | 167 | 0.920 |
Why?
|
Cytokines | 3 | 2015 | 912 | 0.900 |
Why?
|
Odds Ratio | 12 | 2021 | 747 | 0.900 |
Why?
|
Adolescent | 35 | 2024 | 5844 | 0.890 |
Why?
|
Epidemiologic Methods | 2 | 2020 | 65 | 0.850 |
Why?
|
Pregnancy Outcome | 10 | 2022 | 181 | 0.840 |
Why?
|
Phthalic Acids | 5 | 2023 | 36 | 0.810 |
Why?
|
Fertility Preservation | 6 | 2024 | 9 | 0.810 |
Why?
|
Chemokines | 3 | 2014 | 93 | 0.790 |
Why?
|
Research Design | 5 | 2021 | 556 | 0.740 |
Why?
|
Selection Bias | 2 | 2024 | 22 | 0.740 |
Why?
|
Confidence Intervals | 2 | 2020 | 241 | 0.690 |
Why?
|
Disease | 1 | 2020 | 25 | 0.680 |
Why?
|
Infertility, Male | 4 | 2022 | 57 | 0.670 |
Why?
|
Inflammation Mediators | 2 | 2019 | 171 | 0.660 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 2 | 2019 | 30 | 0.650 |
Why?
|
Premature Birth | 3 | 2023 | 108 | 0.640 |
Why?
|
Estradiol | 6 | 2014 | 247 | 0.620 |
Why?
|
Fetal Macrosomia | 2 | 2015 | 12 | 0.620 |
Why?
|
Cigarette Smoking | 2 | 2021 | 53 | 0.610 |
Why?
|
Women's Health | 6 | 2022 | 360 | 0.610 |
Why?
|
Oocytes | 2 | 2017 | 193 | 0.570 |
Why?
|
Age Factors | 16 | 2024 | 1505 | 0.570 |
Why?
|
Smoking | 5 | 2018 | 826 | 0.570 |
Why?
|
Epidemiology | 1 | 2017 | 5 | 0.560 |
Why?
|
Survivors | 7 | 2023 | 150 | 0.560 |
Why?
|
Biology | 1 | 2017 | 24 | 0.550 |
Why?
|
Periodontitis | 1 | 2016 | 15 | 0.530 |
Why?
|
Semen | 4 | 2022 | 42 | 0.520 |
Why?
|
Pregnancy Rate | 8 | 2019 | 29 | 0.510 |
Why?
|
Hot Flashes | 3 | 2024 | 94 | 0.510 |
Why?
|
Ovulation | 2 | 2014 | 28 | 0.500 |
Why?
|
DNA, Mitochondrial | 4 | 2020 | 76 | 0.500 |
Why?
|
Statistics as Topic | 1 | 2016 | 146 | 0.490 |
Why?
|
ROC Curve | 4 | 2018 | 268 | 0.490 |
Why?
|
Alcohol Drinking | 2 | 2021 | 288 | 0.480 |
Why?
|
Cross-Sectional Studies | 15 | 2022 | 2382 | 0.480 |
Why?
|
Middle Aged | 25 | 2024 | 16335 | 0.470 |
Why?
|
Granulocyte Colony-Stimulating Factor | 3 | 2010 | 39 | 0.460 |
Why?
|
Gestational Age | 4 | 2018 | 180 | 0.460 |
Why?
|
Proportional Hazards Models | 7 | 2024 | 674 | 0.450 |
Why?
|
Endometriosis | 3 | 2022 | 24 | 0.440 |
Why?
|
Anovulation | 3 | 2025 | 10 | 0.440 |
Why?
|
Risk Assessment | 8 | 2024 | 1926 | 0.430 |
Why?
|
Limit of Detection | 2 | 2010 | 43 | 0.430 |
Why?
|
Environmental Pollutants | 3 | 2023 | 91 | 0.430 |
Why?
|
Premenopause | 4 | 2022 | 55 | 0.430 |
Why?
|
Health Surveys | 1 | 2014 | 298 | 0.420 |
Why?
|
Abortion, Habitual | 2 | 2018 | 8 | 0.420 |
Why?
|
Diet | 6 | 2019 | 497 | 0.410 |
Why?
|
Infant, Premature | 3 | 2013 | 177 | 0.410 |
Why?
|
Aging | 3 | 2022 | 710 | 0.410 |
Why?
|
Infant Mortality | 2 | 2009 | 19 | 0.410 |
Why?
|
Folic Acid | 2 | 2017 | 41 | 0.400 |
Why?
|
Smoking Cessation | 1 | 2018 | 541 | 0.400 |
Why?
|
Restaurants | 1 | 2012 | 12 | 0.400 |
Why?
|
Extracellular Vesicles | 2 | 2023 | 41 | 0.390 |
Why?
|
Autistic Disorder | 1 | 2014 | 145 | 0.390 |
Why?
|
Parity | 3 | 2021 | 71 | 0.390 |
Why?
|
Embryo Transfer | 3 | 2016 | 23 | 0.390 |
Why?
|
Transients and Migrants | 1 | 2012 | 21 | 0.390 |
Why?
|
Longitudinal Studies | 7 | 2024 | 1188 | 0.390 |
Why?
|
HIV Seropositivity | 1 | 2012 | 82 | 0.380 |
Why?
|
Breast Feeding | 3 | 2021 | 144 | 0.380 |
Why?
|
Cardiovascular Diseases | 6 | 2024 | 789 | 0.380 |
Why?
|
Vitamins | 3 | 2017 | 74 | 0.380 |
Why?
|
United States | 16 | 2024 | 7430 | 0.360 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2010 | 16 | 0.350 |
Why?
|
Breast Neoplasms | 4 | 2024 | 1118 | 0.350 |
Why?
|
Sexual Behavior | 1 | 2012 | 189 | 0.350 |
Why?
|
Paternal Age | 1 | 2010 | 2 | 0.350 |
Why?
|
Epidemiologic Research Design | 1 | 2010 | 3 | 0.350 |
Why?
|
Oocyte Donation | 1 | 2010 | 6 | 0.350 |
Why?
|
Self Report | 5 | 2019 | 359 | 0.350 |
Why?
|
Immunoassay | 1 | 2010 | 68 | 0.340 |
Why?
|
Asthma | 1 | 2014 | 460 | 0.340 |
Why?
|
Primary Ovarian Insufficiency | 2 | 2021 | 7 | 0.330 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2010 | 226 | 0.330 |
Why?
|
Insulin Resistance | 3 | 2024 | 392 | 0.330 |
Why?
|
Embryonic Development | 4 | 2021 | 130 | 0.320 |
Why?
|
Semen Analysis | 4 | 2023 | 20 | 0.320 |
Why?
|
Causality | 3 | 2020 | 57 | 0.320 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2009 | 42 | 0.320 |
Why?
|
Treatment Outcome | 10 | 2024 | 5287 | 0.310 |
Why?
|
Pregnancy Trimester, Second | 1 | 2009 | 34 | 0.310 |
Why?
|
Retrospective Studies | 10 | 2024 | 6081 | 0.310 |
Why?
|
Obstetric Labor, Premature | 1 | 2009 | 31 | 0.310 |
Why?
|
Antineoplastic Agents | 3 | 2024 | 628 | 0.300 |
Why?
|
Male | 27 | 2023 | 27775 | 0.300 |
Why?
|
Obesity | 8 | 2024 | 1166 | 0.300 |
Why?
|
Body Mass Index | 9 | 2024 | 831 | 0.300 |
Why?
|
Cryopreservation | 2 | 2008 | 27 | 0.300 |
Why?
|
Dietary Proteins | 2 | 2019 | 42 | 0.300 |
Why?
|
Creatinine | 2 | 2021 | 128 | 0.290 |
Why?
|
Multivariate Analysis | 4 | 2019 | 903 | 0.290 |
Why?
|
Infant, Newborn | 8 | 2023 | 1286 | 0.290 |
Why?
|
Calcium | 2 | 2017 | 557 | 0.290 |
Why?
|
Thrombopoietin | 1 | 2007 | 9 | 0.290 |
Why?
|
DNA Methylation | 2 | 2021 | 272 | 0.280 |
Why?
|
Predictive Value of Tests | 4 | 2018 | 1028 | 0.280 |
Why?
|
Dietary Fats | 2 | 2019 | 173 | 0.280 |
Why?
|
Ovarian Neoplasms | 2 | 2024 | 130 | 0.270 |
Why?
|
Contraception Behavior | 2 | 2019 | 35 | 0.270 |
Why?
|
Pregnancy Complications | 4 | 2020 | 364 | 0.270 |
Why?
|
Interleukin-6 | 3 | 2019 | 309 | 0.270 |
Why?
|
Surveys and Questionnaires | 13 | 2024 | 2517 | 0.270 |
Why?
|
Nurses | 4 | 2024 | 102 | 0.260 |
Why?
|
MicroRNAs | 2 | 2023 | 618 | 0.260 |
Why?
|
Health Status Indicators | 1 | 2007 | 93 | 0.260 |
Why?
|
Vitamin D | 2 | 2018 | 132 | 0.260 |
Why?
|
Dose-Response Relationship, Drug | 6 | 2018 | 805 | 0.260 |
Why?
|
Prednisone | 1 | 2006 | 85 | 0.260 |
Why?
|
C-Reactive Protein | 3 | 2019 | 159 | 0.260 |
Why?
|
Stress, Psychological | 4 | 2021 | 442 | 0.250 |
Why?
|
Feeding Behavior | 2 | 2018 | 254 | 0.250 |
Why?
|
Postpartum Period | 2 | 2024 | 187 | 0.240 |
Why?
|
Hyperglycemia | 1 | 2005 | 98 | 0.240 |
Why?
|
Heterosexuality | 1 | 2024 | 9 | 0.240 |
Why?
|
Semen Preservation | 1 | 2004 | 5 | 0.230 |
Why?
|
Prevalence | 6 | 2018 | 1257 | 0.230 |
Why?
|
Overweight | 2 | 2024 | 238 | 0.230 |
Why?
|
Patient Admission | 1 | 2005 | 184 | 0.220 |
Why?
|
Menarche | 3 | 2021 | 35 | 0.220 |
Why?
|
Sensitivity and Specificity | 3 | 2020 | 1097 | 0.220 |
Why?
|
Dietary Fiber | 2 | 2018 | 72 | 0.210 |
Why?
|
Reproductive Behavior | 2 | 2020 | 4 | 0.210 |
Why?
|
Emotions | 2 | 2017 | 215 | 0.210 |
Why?
|
Sexual and Gender Minorities | 2 | 2024 | 70 | 0.210 |
Why?
|
Mitochondria | 2 | 2018 | 343 | 0.210 |
Why?
|
Pre-Eclampsia | 2 | 2022 | 70 | 0.210 |
Why?
|
RNA, Small Untranslated | 1 | 2023 | 18 | 0.210 |
Why?
|
Risk | 3 | 2017 | 364 | 0.210 |
Why?
|
Cholesterol | 1 | 2004 | 253 | 0.210 |
Why?
|
Embryo Implantation | 4 | 2012 | 21 | 0.210 |
Why?
|
Socioeconomic Factors | 6 | 2021 | 742 | 0.210 |
Why?
|
National Institute of Child Health and Human Development (U.S.) | 1 | 2022 | 5 | 0.200 |
Why?
|
Environmental Exposure | 4 | 2023 | 208 | 0.200 |
Why?
|
Contraception | 3 | 2021 | 67 | 0.200 |
Why?
|
Fetal Development | 1 | 2022 | 16 | 0.200 |
Why?
|
Urinary Incontinence | 1 | 2022 | 40 | 0.200 |
Why?
|
Sleep | 1 | 2025 | 215 | 0.190 |
Why?
|
Alcoholic Beverages | 1 | 2021 | 6 | 0.190 |
Why?
|
Intensive Care Units | 1 | 2005 | 430 | 0.190 |
Why?
|
Diethylstilbestrol | 1 | 2022 | 49 | 0.190 |
Why?
|
Sterilization, Tubal | 1 | 2021 | 10 | 0.190 |
Why?
|
Dairy Products | 2 | 2019 | 15 | 0.190 |
Why?
|
Reproductive Health Services | 1 | 2021 | 13 | 0.190 |
Why?
|
Sleep Wake Disorders | 1 | 2022 | 65 | 0.190 |
Why?
|
Interleukin-8 | 2 | 2015 | 87 | 0.190 |
Why?
|
Circadian Rhythm | 1 | 2025 | 373 | 0.180 |
Why?
|
Life Style | 4 | 2024 | 299 | 0.180 |
Why?
|
DNA Copy Number Variations | 2 | 2019 | 65 | 0.180 |
Why?
|
Endocrine Glands | 1 | 2021 | 6 | 0.180 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2022 | 158 | 0.180 |
Why?
|
Cadmium | 1 | 2021 | 12 | 0.180 |
Why?
|
Racism | 1 | 2022 | 81 | 0.180 |
Why?
|
Hospital Mortality | 1 | 2005 | 845 | 0.180 |
Why?
|
Computer Simulation | 4 | 2012 | 459 | 0.180 |
Why?
|
Time Factors | 8 | 2024 | 3621 | 0.180 |
Why?
|
Follow-Up Studies | 7 | 2021 | 2339 | 0.180 |
Why?
|
Colorectal Neoplasms | 1 | 2024 | 263 | 0.180 |
Why?
|
Health Behavior | 4 | 2018 | 452 | 0.180 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2015 | 678 | 0.180 |
Why?
|
Eating | 2 | 2019 | 130 | 0.170 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2022 | 151 | 0.170 |
Why?
|
Reproductive Medicine | 1 | 2020 | 5 | 0.170 |
Why?
|
Ovarian Follicle | 2 | 2012 | 39 | 0.170 |
Why?
|
RNA, Long Noncoding | 1 | 2022 | 152 | 0.170 |
Why?
|
Reference Values | 3 | 2015 | 326 | 0.170 |
Why?
|
Insurance, Health | 1 | 2021 | 144 | 0.170 |
Why?
|
Incidence | 6 | 2020 | 1239 | 0.170 |
Why?
|
Preconception Care | 1 | 2020 | 23 | 0.170 |
Why?
|
Meta-Analysis as Topic | 3 | 2009 | 77 | 0.170 |
Why?
|
Rural Population | 1 | 2021 | 188 | 0.160 |
Why?
|
Comorbidity | 3 | 2023 | 1078 | 0.160 |
Why?
|
Interferon-gamma | 2 | 2015 | 551 | 0.160 |
Why?
|
Algorithms | 3 | 2018 | 978 | 0.160 |
Why?
|
Suicide | 1 | 2020 | 119 | 0.160 |
Why?
|
Child | 6 | 2022 | 4194 | 0.160 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2015 | 588 | 0.150 |
Why?
|
Massachusetts | 7 | 2024 | 2022 | 0.150 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2013 | 202 | 0.150 |
Why?
|
Inflammation | 3 | 2015 | 1099 | 0.150 |
Why?
|
Menstruation Disturbances | 1 | 2018 | 18 | 0.150 |
Why?
|
Depression | 2 | 2015 | 829 | 0.150 |
Why?
|
Sperm Motility | 1 | 2018 | 47 | 0.150 |
Why?
|
Contraception, Postcoital | 1 | 2018 | 4 | 0.150 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2018 | 11 | 0.150 |
Why?
|
Perception | 1 | 2019 | 168 | 0.150 |
Why?
|
Nutritional Status | 1 | 2018 | 92 | 0.140 |
Why?
|
Data Accuracy | 1 | 2018 | 28 | 0.140 |
Why?
|
Dietary Carbohydrates | 1 | 2018 | 58 | 0.140 |
Why?
|
Public Health Surveillance | 1 | 2017 | 28 | 0.140 |
Why?
|
Natural Language Processing | 1 | 2018 | 47 | 0.140 |
Why?
|
Calcium, Dietary | 1 | 2017 | 29 | 0.140 |
Why?
|
Paternal Exposure | 1 | 2016 | 5 | 0.140 |
Why?
|
Adoption | 1 | 2016 | 2 | 0.140 |
Why?
|
Maternal Exposure | 1 | 2016 | 39 | 0.130 |
Why?
|
Referral and Consultation | 1 | 2020 | 406 | 0.130 |
Why?
|
Area Under Curve | 1 | 2017 | 141 | 0.130 |
Why?
|
Pandemics | 1 | 2021 | 617 | 0.130 |
Why?
|
Survival Rate | 4 | 2017 | 801 | 0.130 |
Why?
|
Observational Studies as Topic | 1 | 2016 | 55 | 0.130 |
Why?
|
Fatty Acids | 1 | 2017 | 191 | 0.130 |
Why?
|
Models, Biological | 2 | 2020 | 1143 | 0.130 |
Why?
|
Blood Pressure | 2 | 2016 | 496 | 0.130 |
Why?
|
Trinucleotide Repeats | 1 | 2016 | 17 | 0.130 |
Why?
|
Counseling | 1 | 2018 | 350 | 0.130 |
Why?
|
Walking | 1 | 2018 | 228 | 0.130 |
Why?
|
Decision Making | 3 | 2020 | 395 | 0.130 |
Why?
|
Prognosis | 4 | 2021 | 1597 | 0.120 |
Why?
|
Health Promotion | 2 | 2017 | 471 | 0.120 |
Why?
|
Endocrine Disruptors | 1 | 2016 | 73 | 0.120 |
Why?
|
Fragile X Mental Retardation Protein | 1 | 2016 | 38 | 0.120 |
Why?
|
Mouth Diseases | 1 | 2015 | 13 | 0.120 |
Why?
|
Sperm Count | 3 | 2020 | 15 | 0.120 |
Why?
|
Behavioral Risk Factor Surveillance System | 1 | 2015 | 43 | 0.120 |
Why?
|
Interleukin-5 | 1 | 2015 | 40 | 0.120 |
Why?
|
Interleukin-7 | 1 | 2015 | 30 | 0.120 |
Why?
|
Interleukin-13 | 1 | 2015 | 37 | 0.120 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2015 | 73 | 0.120 |
Why?
|
Interleukin-4 | 1 | 2015 | 145 | 0.120 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2020 | 725 | 0.120 |
Why?
|
Myelin Sheath | 1 | 2014 | 34 | 0.120 |
Why?
|
Interleukin-12 | 1 | 2015 | 123 | 0.120 |
Why?
|
Electronic Health Records | 1 | 2018 | 345 | 0.120 |
Why?
|
Interleukin-2 | 1 | 2015 | 164 | 0.110 |
Why?
|
Oral Health | 1 | 2015 | 62 | 0.110 |
Why?
|
Ovulation Detection | 1 | 2014 | 4 | 0.110 |
Why?
|
Tobacco Smoke Pollution | 1 | 2014 | 57 | 0.110 |
Why?
|
Binge Drinking | 1 | 2014 | 27 | 0.110 |
Why?
|
Domestic Violence | 1 | 2014 | 38 | 0.110 |
Why?
|
Interleukin-10 | 1 | 2015 | 149 | 0.110 |
Why?
|
Crime Victims | 1 | 2014 | 32 | 0.110 |
Why?
|
Antidepressive Agents | 1 | 2015 | 212 | 0.110 |
Why?
|
Prefrontal Cortex | 1 | 2014 | 111 | 0.110 |
Why?
|
Sex Offenses | 1 | 2014 | 46 | 0.110 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2018 | 381 | 0.110 |
Why?
|
Insemination, Artificial | 1 | 2013 | 3 | 0.110 |
Why?
|
Hypertension | 2 | 2016 | 570 | 0.110 |
Why?
|
Luteal Phase | 1 | 2013 | 28 | 0.110 |
Why?
|
Interleukin-1beta | 1 | 2015 | 258 | 0.110 |
Why?
|
Labor Stage, Second | 1 | 2013 | 5 | 0.110 |
Why?
|
White Matter | 1 | 2014 | 114 | 0.110 |
Why?
|
Labor Presentation | 1 | 2013 | 3 | 0.110 |
Why?
|
Adult Survivors of Child Abuse | 1 | 2012 | 13 | 0.100 |
Why?
|
Veterans | 1 | 2020 | 728 | 0.100 |
Why?
|
Infant, Premature, Diseases | 1 | 2013 | 45 | 0.100 |
Why?
|
Delivery, Obstetric | 2 | 2013 | 51 | 0.100 |
Why?
|
Metabolic Syndrome | 2 | 2024 | 131 | 0.100 |
Why?
|
Namibia | 1 | 2012 | 1 | 0.100 |
Why?
|
Cerebral Hemorrhage | 1 | 2013 | 85 | 0.100 |
Why?
|
Mendelian Randomization Analysis | 1 | 2012 | 11 | 0.100 |
Why?
|
Bilirubin | 1 | 2012 | 17 | 0.100 |
Why?
|
Anxiety | 1 | 2015 | 387 | 0.100 |
Why?
|
Calcinosis | 2 | 2003 | 79 | 0.100 |
Why?
|
Evidence-Based Medicine | 2 | 2012 | 443 | 0.100 |
Why?
|
Adiposity | 2 | 2022 | 74 | 0.100 |
Why?
|
Fertilization | 1 | 2012 | 78 | 0.090 |
Why?
|
Sexual Partners | 1 | 2012 | 75 | 0.090 |
Why?
|
Ethanol | 1 | 2014 | 306 | 0.090 |
Why?
|
Social Class | 1 | 2012 | 122 | 0.090 |
Why?
|
Alcoholism | 1 | 2014 | 310 | 0.090 |
Why?
|
Reproducibility of Results | 2 | 2007 | 1560 | 0.090 |
Why?
|
Risk-Taking | 1 | 2012 | 158 | 0.090 |
Why?
|
Time-to-Pregnancy | 2 | 2022 | 3 | 0.090 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 451 | 0.090 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2011 | 35 | 0.090 |
Why?
|
Calibration | 1 | 2010 | 67 | 0.090 |
Why?
|
Genotype | 1 | 2012 | 619 | 0.080 |
Why?
|
Age Distribution | 1 | 2010 | 249 | 0.080 |
Why?
|
Coronary Artery Disease | 2 | 2003 | 274 | 0.080 |
Why?
|
Motor Activity | 1 | 2012 | 333 | 0.080 |
Why?
|
Recombinant Proteins | 1 | 2012 | 691 | 0.080 |
Why?
|
Child, Preschool | 1 | 2014 | 1794 | 0.080 |
Why?
|
Diabetes Mellitus | 2 | 2005 | 515 | 0.080 |
Why?
|
Aged | 8 | 2018 | 13426 | 0.080 |
Why?
|
Epigenesis, Genetic | 2 | 2022 | 358 | 0.080 |
Why?
|
Serum | 1 | 2009 | 28 | 0.080 |
Why?
|
Polychlorinated Biphenyls | 2 | 2008 | 39 | 0.080 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2015 | 635 | 0.080 |
Why?
|
Databases, Factual | 1 | 2012 | 814 | 0.080 |
Why?
|
Diet Surveys | 2 | 2019 | 41 | 0.080 |
Why?
|
Androgens | 1 | 2008 | 47 | 0.080 |
Why?
|
Leuprolide | 1 | 2008 | 14 | 0.070 |
Why?
|
Testosterone | 1 | 2008 | 113 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 446 | 0.070 |
Why?
|
Micronutrients | 2 | 2018 | 18 | 0.070 |
Why?
|
Maternal Age | 1 | 2007 | 32 | 0.070 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2007 | 27 | 0.070 |
Why?
|
Sperm Injections, Intracytoplasmic | 1 | 2007 | 32 | 0.070 |
Why?
|
Chemokine CCL3 | 1 | 2007 | 9 | 0.070 |
Why?
|
Macrophage Inflammatory Proteins | 1 | 2007 | 11 | 0.070 |
Why?
|
Chemokine CCL4 | 1 | 2007 | 14 | 0.070 |
Why?
|
Chemokine CXCL5 | 1 | 2007 | 6 | 0.070 |
Why?
|
Chemokine CCL5 | 1 | 2007 | 32 | 0.070 |
Why?
|
Chemokines, CXC | 1 | 2007 | 29 | 0.070 |
Why?
|
Interleukins | 1 | 2007 | 80 | 0.070 |
Why?
|
Blastocyst | 1 | 2008 | 70 | 0.070 |
Why?
|
Chemokine CCL2 | 1 | 2007 | 54 | 0.070 |
Why?
|
Baltimore | 1 | 2007 | 12 | 0.070 |
Why?
|
Austria | 1 | 2006 | 7 | 0.070 |
Why?
|
Matched-Pair Analysis | 1 | 2006 | 10 | 0.070 |
Why?
|
Perimenopause | 1 | 2007 | 31 | 0.070 |
Why?
|
Hematinics | 1 | 2006 | 10 | 0.070 |
Why?
|
Drug Combinations | 1 | 2006 | 147 | 0.070 |
Why?
|
Urban Population | 1 | 2007 | 180 | 0.060 |
Why?
|
APACHE | 1 | 2005 | 47 | 0.060 |
Why?
|
Postmenopause | 1 | 2007 | 224 | 0.060 |
Why?
|
Bisexuality | 1 | 2024 | 14 | 0.060 |
Why?
|
Anti-Inflammatory Agents | 1 | 2006 | 164 | 0.060 |
Why?
|
Sweating | 1 | 2024 | 26 | 0.060 |
Why?
|
Homosexuality, Female | 1 | 2024 | 21 | 0.060 |
Why?
|
Ovarian Diseases | 1 | 2004 | 19 | 0.060 |
Why?
|
Seeds | 1 | 2023 | 31 | 0.050 |
Why?
|
Lipids | 1 | 2005 | 301 | 0.050 |
Why?
|
New York | 2 | 2014 | 134 | 0.050 |
Why?
|
Diabetes Complications | 1 | 2003 | 100 | 0.050 |
Why?
|
Hormone Replacement Therapy | 1 | 2002 | 28 | 0.050 |
Why?
|
RNA, Ribosomal | 1 | 2022 | 53 | 0.050 |
Why?
|
Bayes Theorem | 1 | 2022 | 110 | 0.050 |
Why?
|
Reproductive History | 1 | 2022 | 15 | 0.050 |
Why?
|
Cyclophosphamide | 1 | 2022 | 75 | 0.050 |
Why?
|
Contraceptives, Oral | 1 | 2021 | 22 | 0.050 |
Why?
|
Mexico | 1 | 2021 | 39 | 0.050 |
Why?
|
Dyspnea | 1 | 2022 | 116 | 0.050 |
Why?
|
Critical Care | 1 | 2005 | 399 | 0.050 |
Why?
|
Coronary Disease | 1 | 2002 | 244 | 0.050 |
Why?
|
Weight Gain | 1 | 2022 | 163 | 0.050 |
Why?
|
Blood Glucose | 1 | 2023 | 461 | 0.050 |
Why?
|
Republic of Korea | 1 | 2021 | 29 | 0.050 |
Why?
|
Sex Factors | 2 | 2020 | 935 | 0.040 |
Why?
|
Pituitary-Adrenal System | 1 | 2021 | 60 | 0.040 |
Why?
|
Dried Blood Spot Testing | 1 | 2020 | 3 | 0.040 |
Why?
|
Breast | 1 | 2022 | 174 | 0.040 |
Why?
|
Glucose | 1 | 2023 | 445 | 0.040 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2021 | 88 | 0.040 |
Why?
|
Radiotherapy | 1 | 2020 | 61 | 0.040 |
Why?
|
Sexuality | 1 | 2020 | 25 | 0.040 |
Why?
|
Ovary | 1 | 2020 | 98 | 0.040 |
Why?
|
Texas | 1 | 2020 | 55 | 0.040 |
Why?
|
Asymptomatic Diseases | 1 | 2020 | 46 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2018 | 5129 | 0.040 |
Why?
|
Insulin | 1 | 2023 | 673 | 0.040 |
Why?
|
Pain | 1 | 2022 | 397 | 0.040 |
Why?
|
California | 1 | 2020 | 161 | 0.040 |
Why?
|
Sterilization, Reproductive | 1 | 2019 | 7 | 0.040 |
Why?
|
Intrauterine Devices | 1 | 2019 | 7 | 0.040 |
Why?
|
Health Status Disparities | 1 | 2020 | 137 | 0.040 |
Why?
|
Contraceptive Agents, Female | 1 | 2019 | 24 | 0.040 |
Why?
|
Vitamin D-Binding Protein | 1 | 2018 | 4 | 0.040 |
Why?
|
Pregnenes | 1 | 2018 | 1 | 0.040 |
Why?
|
Sequence Deletion | 1 | 2019 | 112 | 0.040 |
Why?
|
Contraceptives, Postcoital | 1 | 2018 | 5 | 0.040 |
Why?
|
Psychological Trauma | 1 | 2018 | 20 | 0.040 |
Why?
|
Probability | 1 | 2018 | 168 | 0.040 |
Why?
|
Psychometrics | 1 | 2020 | 362 | 0.040 |
Why?
|
Lipid Peroxidation | 1 | 2018 | 63 | 0.040 |
Why?
|
Stearic Acids | 1 | 2017 | 9 | 0.040 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2017 | 15 | 0.040 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2017 | 25 | 0.040 |
Why?
|
Age of Onset | 1 | 2018 | 170 | 0.040 |
Why?
|
Laparoscopy | 1 | 2022 | 427 | 0.040 |
Why?
|
Survivorship | 1 | 2017 | 13 | 0.040 |
Why?
|
DNA Helicases | 1 | 2019 | 187 | 0.030 |
Why?
|
United States Department of Veterans Affairs | 1 | 2020 | 519 | 0.030 |
Why?
|
Blood Pressure Determination | 1 | 2016 | 37 | 0.030 |
Why?
|
Registries | 1 | 2020 | 801 | 0.030 |
Why?
|
Population Surveillance | 1 | 2017 | 195 | 0.030 |
Why?
|
Tooth Loss | 1 | 2015 | 8 | 0.030 |
Why?
|
Family Planning Services | 1 | 2015 | 22 | 0.030 |
Why?
|
Dietary Supplements | 1 | 2017 | 222 | 0.030 |
Why?
|
Health Status | 1 | 2017 | 426 | 0.030 |
Why?
|
Trauma Severity Indices | 1 | 2014 | 34 | 0.030 |
Why?
|
Urinalysis | 1 | 2014 | 30 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 706 | 0.030 |
Why?
|
Rats, Wistar | 1 | 2014 | 179 | 0.030 |
Why?
|
Healthy Volunteers | 1 | 2014 | 66 | 0.030 |
Why?
|
Clomiphene | 1 | 2013 | 2 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2012 | 1482 | 0.030 |
Why?
|
Patient Readmission | 1 | 2018 | 421 | 0.030 |
Why?
|
Child Abuse, Sexual | 1 | 2012 | 25 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2013 | 284 | 0.030 |
Why?
|
Parents | 1 | 2016 | 367 | 0.030 |
Why?
|
Transportation | 1 | 2012 | 32 | 0.020 |
Why?
|
Adaptation, Psychological | 1 | 2014 | 259 | 0.020 |
Why?
|
Cholesterol, LDL | 1 | 2012 | 102 | 0.020 |
Why?
|
Guidelines as Topic | 1 | 2012 | 154 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2013 | 715 | 0.020 |
Why?
|
Ovulation Prediction | 1 | 2011 | 2 | 0.020 |
Why?
|
Child Abuse | 1 | 2012 | 89 | 0.020 |
Why?
|
Linear Models | 1 | 2012 | 403 | 0.020 |
Why?
|
Rats | 1 | 2014 | 1911 | 0.020 |
Why?
|
Puerto Rico | 1 | 2011 | 134 | 0.020 |
Why?
|
Risk Reduction Behavior | 1 | 2011 | 121 | 0.020 |
Why?
|
Diagnostic Self Evaluation | 1 | 2010 | 23 | 0.020 |
Why?
|
Waist Circumference | 1 | 2010 | 45 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2012 | 296 | 0.020 |
Why?
|
Body Height | 1 | 2010 | 68 | 0.020 |
Why?
|
Diet Records | 1 | 2009 | 34 | 0.020 |
Why?
|
Chronic Disease | 1 | 2012 | 717 | 0.020 |
Why?
|
Infant, Low Birth Weight | 1 | 2009 | 56 | 0.020 |
Why?
|
Maternal Behavior | 1 | 2009 | 31 | 0.020 |
Why?
|
Educational Status | 1 | 2010 | 264 | 0.020 |
Why?
|
Hyperandrogenism | 1 | 2008 | 3 | 0.020 |
Why?
|
Corpus Luteum | 1 | 2008 | 8 | 0.020 |
Why?
|
Sample Size | 1 | 2008 | 61 | 0.020 |
Why?
|
Chorionic Gonadotropin | 1 | 2008 | 14 | 0.020 |
Why?
|
Embryo Culture Techniques | 1 | 2008 | 10 | 0.020 |
Why?
|
Treatment Failure | 1 | 2008 | 185 | 0.020 |
Why?
|
Infant | 1 | 2011 | 1493 | 0.020 |
Why?
|
Statistical Distributions | 1 | 2006 | 2 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2006 | 88 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2008 | 933 | 0.020 |
Why?
|
Patient Selection | 1 | 2008 | 465 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2003 | 1512 | 0.020 |
Why?
|
Pilot Projects | 1 | 2008 | 915 | 0.010 |
Why?
|
Biomarkers, Tumor | 1 | 2008 | 461 | 0.010 |
Why?
|
Environmental Monitoring | 1 | 2005 | 127 | 0.010 |
Why?
|
Los Angeles | 1 | 2002 | 11 | 0.010 |
Why?
|
Lipoproteins, LDL | 1 | 2002 | 45 | 0.010 |
Why?
|
Animals | 1 | 2014 | 19661 | 0.010 |
Why?
|